US cancer network recommending expensive drugs based on weak evidence, study finds

Share this post

Study raises concerns about National Comprehensive Cancer Network, which publishes guidelines for American oncologists

Guidelines for American oncologists often recommend expensive and harmful cancer drugs for patients based on “weak evidence�, according to a new study in the British Medical Journal.

Related: Cancer patients shed new light on rheumatoid arthritis

Continue reading…

This post was syndicated from Health | The Guardian. Click here to read the full text on the original website.

Share this post

Be the first to comment

Leave a Reply